RESUMEN
INTRODUCTION: Monitored anesthesia care (MAC) or general anesthesia (GA) can be used during catheter ablation (CA) of atrial fibrillation (AF). However, each approach may have advantages and disadvantages with variability in operator preferences. The optimal approach has not been well established. The purpose of this study was to compare procedural efficacy, safety, clinical outcomes, and cost of CA for AF performed with MAC versus GA. METHODS: The study population consisted of 810 consecutive patients (mean age: 63 ± 10 years, paroxysmal AF: 48%) who underwent a first CA for AF. All patients completed a preprocedural evaluation by the anesthesiologists. Among the 810 patients, MAC was used in 534 (66%) and GA in 276 (34%). Ten patients (1.5%) had to convert to GA during the CA. RESULTS: Although the total anesthesia care was longer with GA particularly in patients with persistent AF, CA was shorter by 5 min with GA than MAC (p < 0.01). Prevalence of perioperative complications was similar between the two groups (4% vs. 4%, p = 0.89). There was no atrioesophageal fistula with either approach. GA was associated with a small, ~7% increase in total charges due to longer anesthesia care. During 43 ± 17 months of follow-up after a single ablation procedure, 271/534 patients (51%) in the MAC and 129/276 (47%) patients in the GA groups were in sinus rhythm without concomitant antiarrhythmic drug therapy (p = 0.28). CONCLUSION: With the participation of an anesthesiologist, and proper preoperative assessment, CA of AF using GA or MAC has similar efficacy and safety.
Asunto(s)
Fibrilación Atrial , Ablación por Catéter , Anciano , Anestesia General/efectos adversos , Antiarrítmicos , Fibrilación Atrial/diagnóstico , Fibrilación Atrial/epidemiología , Fibrilación Atrial/cirugía , Ablación por Catéter/efectos adversos , Humanos , Persona de Mediana Edad , Resultado del TratamientoRESUMEN
INTRODUCTION: Although noninferiority of cryoballoon ablation (CBA) and radiofrequency catheter ablation for antral pulmonary vein isolation (APVI) has been reported in patients with paroxysmal atrial fibrillation (PAF), it is not clear whether contact force sensing (CF-RFA) and CBA with the second-generation catheter have similar procedural costs and long-term outcomes. The objective of this study is to compare the long-term efficacy and cost implications of CBA and CF-RFA in patients with PAF. METHODS AND RESULTS: A first APVI was performed in 146 consecutive patients (age: 63 ± 10 years, men: 95 [65%], left atrial diameter: 42 ± 6 mm) with PAF using CBA (71) or CF-RFA (75). Clinical outcomes and procedural costs were compared. The mean procedure time was significantly shorter with CBA than with CF-RFA (98 ± 39 vs. 158 ± 47 minutes, P < 0.0001). Despite a higher equipment cost in the CBA than the CF-RFA group, the total procedure cost was similar between the two groups (P = 0.26), primarily driven by a shorter procedure duration that resulted in a lower anesthesia cost. At 25 ± 5 months after a single ablation procedure, 51 patients (72%) in the CBA, and 55 patients (73%) in the CF-RFA groups remained free from atrial arrhythmias without antiarrhythmic drug therapy (P = 0.84). CONCLUSIONS: The procedure duration was approximately 60 minutes shorter with CBA than CF-RFA. The procedural costs were similar with both approaches. At 2 years after a single procedure, CBA and CF-RFA have similar single-procedure efficacies of 72-73%.
Asunto(s)
Fibrilación Atrial/economía , Fibrilación Atrial/cirugía , Ablación por Catéter/economía , Criocirugía/economía , Costos de Hospital , Venas Pulmonares/cirugía , Potenciales de Acción , Anciano , Anestesia/economía , Antiarrítmicos/economía , Antiarrítmicos/uso terapéutico , Fibrilación Atrial/diagnóstico , Fibrilación Atrial/fisiopatología , Ablación por Catéter/efectos adversos , Criocirugía/efectos adversos , Costos de los Medicamentos , Técnicas Electrofisiológicas Cardíacas/economía , Femenino , Frecuencia Cardíaca , Humanos , Masculino , Persona de Mediana Edad , Tempo Operativo , Supervivencia sin Progresión , Venas Pulmonares/fisiopatología , Recurrencia , Reoperación/economía , Estudios Retrospectivos , Factores de TiempoRESUMEN
As a major expense driver to cardiovascular programs, supply costs related to electrophysiology and cardiac catheterization procedures directly link to the overall financial health of organizations associated with those programs. Because of this, it is important that institutions establish a logical and resolute approach to obtaining supply pricing that maximizes cost-saving opportunities, buffers their organizations from escalating costs related to the advances in available technologies, defines supply chain expectations while preserving clinicians' access to high-quality cardiovascular supplies, and maintains the availability of the full spectrum of products to our physicians, referring physicians, and patients. In a joint effort with physicians, administration, and suppliers, and in the spirit of partnership, the University of Michigan Health System has developed and implemented such a model that illustrates the opportunities to be gained.
Asunto(s)
Enfermedades Cardiovasculares , Conducta Cooperativa , Equipos y Suministros de Hospitales/economía , Adquisición en Grupo , Negociación , Control de Costos , Humanos , Estados UnidosRESUMEN
In an attempt to further reduce operating costs, in 2004 our institution embarked on a novel approach in which we defined the price to be paid for interventional cardiology supplies and challenged vendors to meet that price. The results suggest that this strategy can further reduce supply costs while maintaining collaborative relationships with vendors.
Asunto(s)
Servicio de Cardiología en Hospital , Propuestas de Licitación , Contratos , Equipos y Suministros de Hospitales/economía , Centros Médicos Académicos , Conducta Cooperativa , MichiganRESUMEN
Over the past decade, the financial pressures from variations in reimbursement and payer mix, combined with rapidly evolving technology, has forced healthcare institutions in the United States to seek out further options for cost savings. In the arena of interventional cardiology, the ability to successfully negotiate the lowest possible cost for a relatively small number of high-cost devices can result in significant savings. Historically, competitive bidding with market-share guarantee to a preferred vendor or two initially resulted in moderate cost savings. However, in 2003 our institution embarked on a novel approach in which we defined the price to be paid, and we challenged our vendors to meet that price. Early results of this aggressive strategy suggest that it is a successful technique in reducing supply costs and maintaining collaborative relationships with vendors while remaining fair and competitive.